Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Sep 22, 2021

Axonics® Provides Additional Update on Inter Partes Review Proceedings

Sep 13, 2021

Axonics® Announces Partial Decision on Inter Partes Review Proceedings

Aug 27, 2021

Axonics® to Participate in Upcoming Investor Conferences

Aug 05, 2021

Axonics® Reports Second Quarter 2021 Financial Results

Jul 15, 2021

Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

Jul 08, 2021

Axonics® to Report Second Quarter 2021 Financial Results on August 5, 2021

Jun 24, 2021

Axonics® Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral Neurostimulator

May 20, 2021

Axonics® Receives FDA Approval Further Expanding MRI Labeling

May 18, 2021

Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval

May 14, 2021

Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics, Inc. Axonics^® is a trademark of Axonics, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap